Literature DB >> 17560084

Establishment of SV40T-transformed human dermal papilla cells and identification of dihydrotestosterone-regulated genes by cDNA microarray.

Sang Yoon Park1, Mi Hee Kwack, Eun Jung Chung, Sang Uk Im, In Sook Han, Moon Kyu Kim, Jung Chul Kim, Young Kwan Sung.   

Abstract

BACKGROUND: Recent studies suggest that androgens are the main regulator of changes in human hair growth, and dermal papilla (DP) is known to secret factors which regulate the growth and activity of the cells in the follicle in response to androgens. However, published data of androgen-regulated genes in human dermal papilla cells is limited and genome-wide large scale screening has not been reported.
OBJECTIVE: To identify the dihydrotestosterone (DHT)-regulated genes in human dermal papilla cells.
METHODS: SV40T-transformed human dermal papilla cell line (SV40T-DPC) was established and DHT-regulated genes were screened by cDNA microarray analysis.
RESULTS: SV40T-DPC maintained early passage morphology and expressed functional androgen receptors. cDNA microarray followed by RT-PCR analysis showed that a number of genes are regulated by DHT in SV40T-DPC.
CONCLUSION: The DHT-regulated genes reported in this study may be involved in androgen-mediated regulation of hair growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560084     DOI: 10.1016/j.jdermsci.2007.04.005

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  3 in total

1.  Tissue-selective regulation of androgen-responsive genes.

Authors:  Maya Otto-Duessel; Miaoling He; Jeremy O Jones
Journal:  Endocr Res       Date:  2012-05-16       Impact factor: 1.720

2.  An appraisal of laboratory models of androgenetic alopecia: A systematic review.

Authors:  S Ntshingila; N P Khumalo; M Engel; A T Arowolo
Journal:  Skin Health Dis       Date:  2021-03-05

3.  7-Phloroeckol promotes hair growth on human follicles in vitro.

Authors:  Soon-Sun Bak; Young Kwan Sung; Se-Kwon Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-16       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.